"gene"	"adj.pval.Initial.Treatment"	"adj.pval.treatment"	"adj.pval.treatment1"	"adj.pval.treatment2"	"adj.pval.treatment1_x_treatment2"	"scaffold"	"start"	"end"	"uniprot.id"	"uniprot_taxa.id"	"Uniprot.Name"	"GO.IDs"	"GO.Descript"
"PGEN_.00g000280"	0.00756635905466832	0.00567281456865247	1.71285378317722e-07	0.627146382426752	8.25221706959982e-06	"Scaffold_01"	402378	436712	"Q8ZXT3"	"Y1111_PYRAE"	"Uncharacterized protein PAE1111"	""	""
"PGEN_.00g001170"	0.0105803992721356	7.46116355541912e-17	0.000472789628747175	0.033074265646583	0.000541185065189269	"Scaffold_01"	2366888	2417042	"Q66HA5"	"C2D1A_RAT"	"Coiled-coil and C2 domain-containing protein 1A (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1)"	"GO:0000122; GO:0000978; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886"	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
"PGEN_.00g003320"	6.4846425660795e-11	0.00194149228721815	2.91715424921727e-14	0.0919591737758477	1.31809529355579e-13	"Scaffold_01"	8256420	8256734	NA	NA	NA	NA	NA
"PGEN_.00g003330"	1.04663354759666e-25	8.32124555909596e-13	1.44356797810951e-39	0.69566261327284	8.23140488263426e-05	"Scaffold_01"	8257067	8258104	NA	NA	NA	NA	NA
"PGEN_.00g004840"	0.0323669642199814	0.0180417523405123	0.848129490869109	0.859597413096865	0.686603414082209	"Scaffold_01"	12482981	12539247	"P54646"	"AAPK2_HUMAN"	"5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)"	"GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006853; GO:0007050; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016236; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031669; GO:0032007; GO:0034599; GO:0035174; GO:0035556; GO:0035690; GO:0042149; GO:0042304; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0097009; GO:1901796; GO:1903829; GO:1904428; GO:2000758"	"axon [GO:0030424]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g006120"	0.00198515945663633	0.00536165984914145	0.00120707914284034	0.0711700933806135	0.0363605899148703	"Scaffold_01"	15441130	15455918	NA	NA	NA	NA	NA
"PGEN_.00g009320"	5.98755384917355e-53	0.000564162461790869	3.59103936455488e-06	0.0385197366673949	0.155112327117899	"Scaffold_01"	24301248	24318845	"Q6INU7"	"FRRS1_XENLA"	"Putative ferric-chelate reductase 1 (EC 1.-.-.-)"	"GO:0016021; GO:0016491"	"integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]"
"PGEN_.00g010440"	0.0121805233753179	0.0258825350992354	0.447411354781361	0.625130676241682	0.438732367156855	"Scaffold_01"	27487194	27547063	NA	NA	NA	NA	NA
"PGEN_.00g010450"	9.83020605567345e-12	6.97565456378379e-05	0.0695436596025068	0.506639949671383	0.714518722770542	"Scaffold_01"	27614094	27617495	NA	NA	NA	NA	NA
"PGEN_.00g010510"	5.74955941002062e-09	2.83944271659738e-09	0.376738255618305	0.503554678128563	0.0172093421525472	"Scaffold_01"	27890876	27895358	NA	NA	NA	NA	NA
"PGEN_.00g013900"	0.0047019107511183	7.01528658880582e-08	0.0120701589418665	0.890138793135651	0.45849472530356	"Scaffold_01"	35824608	35872288	"Q80TN7"	"NAV3_MOUSE"	"Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)"	"GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1905929"	"nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of invadopodium disassembly [GO:1905929]; positive regulation of microtubule polymerization [GO:0031116]"
"PGEN_.00g014370"	1.70717113081924e-09	2.05619911356504e-06	0.00406538124388367	0.00259954545912392	0.0104609373332842	"Scaffold_01"	37277926	37336883	"Q11002"	"CANA_DROME"	"Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]"	"GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832"	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]"
"PGEN_.00g015010"	0.0109734019697411	1.04279156491407e-06	0.797261612964958	0.129304069912514	0.342763791304302	"Scaffold_01"	39289419	39293531	"Q80TF4"	"KLH13_MOUSE"	"Kelch-like protein 13 (BTB and kelch domain-containing protein 2)"	"GO:0004842; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301"	"Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]"
"PGEN_.00g015800"	0.0449118287036669	0.00866241581055026	0.0160140018578994	0.0113978152092618	4.87837697157983e-05	"Scaffold_01"	42028001	42054472	"O76840"	"PPN1_CAEEL"	"Papilin (Abnormal cell migration protein 6)"	"GO:0000902; GO:0002119; GO:0004867; GO:0005604; GO:0008233; GO:0009792; GO:0032504; GO:0048598"	"basement membrane [GO:0005604]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell morphogenesis [GO:0000902]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; multicellular organism reproduction [GO:0032504]; nematode larval development [GO:0002119]"
"PGEN_.00g017070"	0.0332767830047335	9.36503694880675e-05	0.334712851533845	6.19417157666832e-07	7.91689619952913e-12	"Scaffold_01"	46195246	46202441	NA	NA	NA	NA	NA
"PGEN_.00g017150"	0.000464836522083192	0.000130783415946329	8.62841046075522e-08	9.65784742381606e-52	3.19003448244804e-07	"Scaffold_01"	46434018	46434647	NA	NA	NA	NA	NA
"PGEN_.00g017310"	1.1764018516626e-10	0.0393726374063086	3.14219525815894e-11	0.137950735410511	0.00012003851666389	"Scaffold_01"	46757099	46776661	NA	NA	NA	NA	NA
"PGEN_.00g017320"	0.027290389182117	2.06356748171059e-19	0.0134026777318015	1.27753824225953e-09	3.14985863888405e-09	"Scaffold_01"	46778649	46781301	NA	NA	NA	NA	NA
"PGEN_.00g017330"	0.00344188696900316	0.0011881184001967	0.673228669191233	2.3897913371254e-09	0.0529522560069557	"Scaffold_01"	46781408	46781914	NA	NA	NA	NA	NA
"PGEN_.00g018310"	0.00425183596767076	1.65730444065069e-05	0.00691207604588237	0.864502906692806	0.59351208345667	"Scaffold_01"	49450969	49487609	NA	NA	NA	NA	NA
"PGEN_.00g024960"	3.67030485762219e-16	0.0159922278912296	2.31416964190717e-09	0.563458053843619	1.83380408240805e-05	"Scaffold_01"	69278011	69280314	"Q6BK42"	"DDI1_DEBHA"	"DNA damage-inducible protein 1 (EC 3.4.23.-)"	"GO:0000149; GO:0004190; GO:0005737; GO:0005886; GO:0009306; GO:0043130; GO:0043328; GO:0045740; GO:0072710"	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; SNARE binding [GO:0000149]; ubiquitin binding [GO:0043130]; positive regulation of DNA replication [GO:0045740]; protein secretion [GO:0009306]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; response to hydroxyurea [GO:0072710]"
"PGEN_.00g026390"	7.31748944995982e-11	3.05855220731865e-50	4.94952395712254e-38	7.75389547332754e-50	0.00179118912946325	"Scaffold_01"	72980147	73044811	NA	NA	NA	NA	NA
"PGEN_.00g026840"	0.011142860610983	0.0188833875127139	0.0516579531621567	1.28169002531436e-10	0.831716523016601	"Scaffold_01"	74227898	74278041	NA	NA	NA	NA	NA
"PGEN_.00g029240"	0.00138516887865956	0.0301793441062283	0.897920984167797	0.0611700013917569	0.108437323081038	"Scaffold_01"	80336882	80352069	"Q86VZ4"	"LRP11_HUMAN"	"Low-density lipoprotein receptor-related protein 11 (LRP-11)"	"GO:0005886; GO:0009408; GO:0009409; GO:0009414; GO:0009612; GO:0016021; GO:0033555; GO:0035902; GO:0042594; GO:0051219"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414]"
"PGEN_.00g031500"	0.0498545326147777	0.0147321366074148	0.221470203269226	0.928210869672753	0.000278799571729025	"Scaffold_01"	86019349	86035420	"Q9WVL1"	"AP4S1_MOUSE"	"AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin)"	"GO:0005802; GO:0006886; GO:0016192; GO:0030124; GO:0043231"	"AP-4 adaptor complex [GO:0030124]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]"
"PGEN_.00g032670"	0.0176975692892726	3.07532140087939e-05	0.235853782108011	0.698748726025852	1.82876656883734e-07	"Scaffold_01"	88357420	88371915	NA	NA	NA	NA	NA
"PGEN_.00g033560"	0.0371111432657221	0.0241944468378098	0.849698990611881	0.722974837374853	0.117060951757539	"Scaffold_02"	941000	997104	"Q922B6"	"TRAF7_MOUSE"	"E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)"	"GO:0000122; GO:0000151; GO:0000185; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0043231; GO:0043410; GO:0048471; GO:0070372; GO:0071354; GO:2001235"	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein sumoylation [GO:0033235]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein localization [GO:0032880]"
"PGEN_.00g034240"	0.00151800002675283	3.11395569396123e-51	1.92079324806683e-08	2.59879592352157e-38	0.00128118103071913	"Scaffold_02"	3271834	3272760	NA	NA	NA	NA	NA
"PGEN_.00g034500"	8.21643305860391e-08	2.64287482044427e-05	0.000190624302300185	0.395430148637166	5.02026203383189e-12	"Scaffold_02"	4049426	4050256	NA	NA	NA	NA	NA
"PGEN_.00g035080"	1.61335887347129e-39	3.12116151225601e-16	3.38493472583218e-27	0.973426373411381	5.3683857543841e-14	"Scaffold_02"	5299978	5302086	NA	NA	NA	NA	NA
"PGEN_.00g035760"	6.25415833796371e-05	0.00293513438187521	0.461416143100555	0.608787491361351	0.745569331952647	"Scaffold_02"	6933686	6957520	"Q13976"	"KGP1_HUMAN"	"cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)"	"GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0016358; GO:0019934; GO:0030036; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:1904706; GO:1904753"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular smooth muscle [GO:0060087]; signal transduction [GO:0007165]"
"PGEN_.00g036880"	6.7768068017116e-10	6.97215194851785e-32	9.69782695304373e-08	1.71331908483891e-09	5.00738589646284e-19	"Scaffold_02"	9717263	9781629	"Q68CJ6"	"SLIP_HUMAN"	"Nuclear GTPase SLIP-GC (EC 3.6.1.-) (Speckled-like pattern in the germinal center)"	"GO:0003924; GO:0005525; GO:0016607; GO:0033262; GO:0043066; GO:0071222"	"nuclear speck [GO:0016607]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262]"
"PGEN_.00g038260"	8.44997324743996e-23	0.00023156672689565	0.0912155126747019	1.49493319012682e-39	2.32085496916331e-11	"Scaffold_02"	13711841	13715006	NA	NA	NA	NA	NA
"PGEN_.00g043300"	1.25631747095955e-10	8.85479637913018e-07	0.0912311450323532	0.381457281914565	0.000284536841817487	"Scaffold_02"	28520130	28523424	"Q07076"	"ANXA7_MOUSE"	"Annexin A7 (Annexin VII) (Annexin-7) (Synexin)"	"GO:0005178; GO:0005509; GO:0005544; GO:0005623; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0030855; GO:0031982; GO:0042584; GO:0042802; GO:0048306; GO:0051592; GO:0061025; GO:0062023"	"cell [GO:0005623]; chromaffin granule membrane [GO:0042584]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]"
"PGEN_.00g043790"	1.30398028402998e-73	3.63775311896135e-210	7.06995124504302e-28	4.24894266454276e-55	3.10546364728877e-20	"Scaffold_02"	29899614	29910977	"P97346"	"NXN_MOUSE"	"Nucleoredoxin (EC 1.8.1.8) (Protein Red-1)"	"GO:0001701; GO:0004791; GO:0005623; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0045454; GO:0047134; GO:0072358"	"cell [GO:0005623]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; in utero embryonic development [GO:0001701]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g044020"	0.0121022333538897	2.27386840731872e-06	0.0291723487286201	0.149967444691797	6.3944289331898e-14	"Scaffold_02"	30569087	30571600	NA	NA	NA	NA	NA
"PGEN_.00g049230"	2.17097606665124e-267	1.56517409318115e-07	3.51843214943228e-35	0.397248409939461	4.54706449003701e-34	"Scaffold_02"	44783604	44801307	NA	NA	NA	NA	NA
"PGEN_.00g049510"	1.6956699451494e-09	0.00046221698864548	0.193507275724893	0.164854787727392	0.862162343443607	"Scaffold_02"	45350315	45373894	"Q8TDM6"	"DLG5_HUMAN"	"Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)"	"GO:0001837; GO:0005737; GO:0005886; GO:0005913; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609"	"cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; receptor signaling complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]"
"PGEN_.00g050170"	0.00341193574831867	2.26966987365854e-10	0.0122988265832504	0.735261932419261	4.77101314052893e-11	"Scaffold_02"	47298190	47299423	NA	NA	NA	NA	NA
"PGEN_.00g050180"	3.73800748080879e-08	1.02899658962513e-09	0.38722808213068	0.820101810707837	0.950322537239316	"Scaffold_02"	47299859	47303590	NA	NA	NA	NA	NA
"PGEN_.00g051410"	3.41644729154677e-07	0.0167015096756542	0.0496802460607271	0.0021590845086765	0.343836410900574	"Scaffold_02"	50737403	50741672	NA	NA	NA	NA	NA
"PGEN_.00g051430"	4.57083963530111e-07	0.000230903736940274	0.743340667592993	0.0275330999195033	3.63899800054801e-06	"Scaffold_02"	50797608	50888432	"Q2HJF4"	"PBLD_BOVIN"	"Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-)"	"GO:0005737; GO:0009058; GO:0010633; GO:0010719; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0050680; GO:0060392; GO:0060394"	"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]"
"PGEN_.00g055620"	3.59141064916459e-08	5.4380359755602e-08	0.000520184480803001	0.619037622669197	0.671779134427608	"Scaffold_02"	62591387	62610230	"Q5R452"	"SAFB1_PONAB"	"Scaffold attachment factor B1 (SAF-B1)"	"GO:0000978; GO:0003682; GO:0003723; GO:0005634; GO:0006355; GO:0050684"	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"
"PGEN_.00g057380"	9.70625896658065e-09	0.0187419299811335	0.310358717401567	7.30328226628941e-12	6.60436949101386e-08	"Scaffold_02"	67898208	67904591	"Q9ESD1"	"PRSS8_MOUSE"	"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]"	"GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0045121; GO:0046658; GO:0070633; GO:1902307"	"anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633]"
"PGEN_.00g060400"	1.99802808666761e-09	0.0214094479527275	0.825394846416433	0.00332756124164344	0.130512305473397	"Scaffold_03"	7144218	7178145	"Q93099"	"HGD_HUMAN"	"Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	"GO:0004411; GO:0005829; GO:0006520; GO:0006559; GO:0006572; GO:0042802; GO:0046872; GO:0070062"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"
"PGEN_.00g060650"	1.53980604300398e-08	1.38178534897576e-05	0.287775721591374	0.079290337699356	0.580190693625506	"Scaffold_03"	7784226	7844346	"Q5THR3"	"EFCB6_HUMAN"	"EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP)"	"GO:0005509; GO:0005654"	"nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]"
"PGEN_.00g062630"	2.56875886841803e-07	0.000239588044053736	0.00189961899382509	0.934560852240742	3.69347621092205e-07	"Scaffold_03"	13089701	13121485	"A0JMD4"	"TPC2_DANRE"	"Two pore calcium channel protein 2 (Voltage-dependent calcium channel protein TPC2)"	"GO:0005245; GO:0005623; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0016021; GO:0019722; GO:0034765; GO:0072345; GO:2000290"	"cell [GO:0005623]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]"
"PGEN_.00g062900"	0.0129700641358931	6.84619456718157e-05	0.0312816886945324	0.0481306399389377	0.000554615861507744	"Scaffold_03"	13950277	13996316	NA	NA	NA	NA	NA
"PGEN_.00g065280"	3.31327546038246e-05	0.000475141864397962	0.424420442446923	0.596170156848761	0.0496874106329156	"Scaffold_03"	20642211	20684453	"Q8BUG5"	"CAYP2_MOUSE"	"Calcyphosin-2 (Calcyphosine-2)"	"GO:0005509"	"calcium ion binding [GO:0005509]"
"PGEN_.00g065330"	0.0143849863554862	3.49043169063813e-08	0.730021450676851	0.294228684996539	0.000576565954924893	"Scaffold_03"	20720165	20723492	NA	NA	NA	NA	NA
"PGEN_.00g065700"	3.19316760791561e-10	1.76680633494292e-08	8.34067118032795e-05	0.0450026932386791	0.700372600745351	"Scaffold_03"	21395485	21421405	"P80174"	"SODC_CARCR"	"Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)"	"GO:0004784; GO:0005634; GO:0005737; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]"
"PGEN_.00g065950"	1.70627465124926e-06	0.00898781535602424	0.952282092963167	0.314824811377977	0.403121353607056	"Scaffold_03"	22305616	22370797	"O73925"	"KCNQ1_SQUAC"	"Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)"	"GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009"	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]"
"PGEN_.00g066200"	0.000132304838708539	0.00967821651399364	3.39173440983547e-06	0.58090120071781	2.60359849557757e-05	"Scaffold_03"	23345122	23347681	NA	NA	NA	NA	NA
"PGEN_.00g067240"	5.09459674587625e-05	3.2223023033734e-14	0.84042553627542	0.58050305951487	0.0756723930329098	"Scaffold_03"	25938530	25940805	NA	NA	NA	NA	NA
"PGEN_.00g067860"	0.00923811077352171	0.00311028341103771	0.0660399697349824	0.448425441626553	0.0124396964016345	"Scaffold_03"	27382342	27389374	NA	NA	NA	NA	NA
"PGEN_.00g068680"	1.9924123266612e-15	1.04456015826096e-06	0.06928057361712	0.0981462955501005	0.133108298014679	"Scaffold_03"	29458858	29464104	NA	NA	NA	NA	NA
"PGEN_.00g068720"	4.69321516489737e-50	1.18893088534073e-31	3.7206938691062e-14	3.04824651422142e-09	6.4607005212228e-28	"Scaffold_03"	29524834	29525839	NA	NA	NA	NA	NA
"PGEN_.00g069450"	5.18976814021615e-07	3.6662477397628e-12	0.00654558973893187	0.222079767293808	0.260952091964737	"Scaffold_03"	32158794	32161618	"Q7Z5P9"	"MUC19_HUMAN"	"Mucin-19 (MUC-19)"	"GO:0002223; GO:0005576; GO:0005796; GO:0005886; GO:0016266"	"extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
"PGEN_.00g069610"	8.50006180782909e-14	4.94417187521176e-06	0.000144644115395024	0.00282750347505024	2.59508908651369e-11	"Scaffold_03"	32387002	32406962	NA	NA	NA	NA	NA
"PGEN_.00g069870"	0.0359091976835736	2.76537071508365e-13	0.00382258393690529	0.149967444691797	0.416816280236536	"Scaffold_03"	32918963	32934808	NA	NA	NA	NA	NA
"PGEN_.00g070630"	0.0105710009237872	0.0123466477358793	0.865504593231102	0.849410160857633	0.394488045134784	"Scaffold_03"	35313437	35320513	"Q2TBS9"	"SMU1_BOVIN"	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	"GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005"	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
"PGEN_.00g072260"	0.00767252090629021	0.00439561497746984	0.195622403792151	0.807370141407523	7.61334348649207e-05	"Scaffold_03"	40153408	40163087	"Q5XXP2"	"OPN4_PHOSU"	"Melanopsin (Opsin-4)"	"GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0018298; GO:0042752; GO:0048511"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]"
"PGEN_.00g073580"	2.39233811081345e-21	1.62998260634609e-45	0.265948515821603	0.0899267669831178	3.51522634915548e-08	"Scaffold_03"	43761204	43771849	NA	NA	NA	NA	NA
"PGEN_.00g075700"	4.36922697143846e-05	7.39107765647679e-69	0.741343574075467	0.368163817466767	0.146970481726388	"Scaffold_03"	50726782	50795337	"B3EWY9"	"MLP_ACRMI"	"Mucin-like protein (Fragment)"	"GO:0005509; GO:0007160; GO:0016021"	"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]"
"PGEN_.00g076180"	2.85122931109085e-09	5.98512183227016e-10	4.50704695633396e-05	0.677303399392791	2.49134297273664e-09	"Scaffold_03"	51960428	51967440	"Q8JHV9"	"BIR7A_XENLA"	"Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)"	"GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865"	"cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]"
"PGEN_.00g077070"	5.82211511589329e-05	1.2011252793742e-10	0.0479839768969098	0.722974837374853	0.033890904695957	"Scaffold_03"	54609767	54610342	NA	NA	NA	NA	NA
"PGEN_.00g078310"	0.00677752411758388	0.000982591514099736	0.0282720258767977	0.717104279031869	0.00746888456473829	"Scaffold_03"	57399874	57483677	"P35992"	"PTP10_DROME"	"Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)"	"GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446"	"apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]"
"PGEN_.00g080870"	0.000204824887406086	1.07001251708592e-07	0.0145382405460513	0.237955633026324	3.65376527610571e-09	"Scaffold_04"	6303439	6316236	NA	NA	NA	NA	NA
"PGEN_.00g082390"	3.45331582058002e-07	0.0355587663372623	2.25861417678572e-06	0.250433612389597	0.0831613958475597	"Scaffold_04"	9894020	9900405	"Q8BR93"	"HARB1_MOUSE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872"	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g090230"	1.02209533398923e-07	3.43577783722719e-07	0.251587707337026	0.663618016135141	0.00067227284623058	"Scaffold_04"	30404333	30417979	NA	NA	NA	NA	NA
"PGEN_.00g096230"	0.000133941672470567	0.0132102743232045	0.00685520497308933	0.52615177618353	0.416792921457829	"Scaffold_04"	46322021	46334683	NA	NA	NA	NA	NA
"PGEN_.00g097340"	1.33527339173933e-05	0.00124364682324092	0.0670995545913153	0.00515162641485222	0.399230937636203	"Scaffold_04"	49379820	49380767	NA	NA	NA	NA	NA
"PGEN_.00g097550"	5.85279948570918e-17	3.79287266928977e-10	7.05322613392785e-15	0.349760922881058	4.38801377538975e-27	"Scaffold_04"	49794445	49794803	NA	NA	NA	NA	NA
"PGEN_.00g100950"	1.78002871676837e-10	4.64671385314935e-05	0.00209953273862376	1.0073534243551e-17	0.0630178688853394	"Scaffold_04"	57885900	57886430	NA	NA	NA	NA	NA
"PGEN_.00g101020"	4.26800333550066e-05	0.00757655908928367	4.834369877021e-05	0.655597478781302	0.00146053868090002	"Scaffold_04"	57942638	57943782	NA	NA	NA	NA	NA
"PGEN_.00g101030"	1.81813409680696e-46	0.000533268163163478	0.00193661836844924	3.96202213405499e-39	1.22921960666354e-35	"Scaffold_04"	57953649	57955140	NA	NA	NA	NA	NA
"PGEN_.00g101840"	3.27615934492435e-41	0.000265388102327244	0.980539669572362	0.16782147805304	0.854914676728467	"Scaffold_04"	60033809	60065559	"Q8R197"	"SAST_MOUSE"	"S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1)"	"GO:0004320; GO:0005829; GO:0008610; GO:0016295; GO:0016296; GO:0016297; GO:0047381; GO:0051792"	"cytosol [GO:0005829]; acyl-[acyl-carrier-protein] hydrolase activity [GO:0016297]; dodecanoyl-[acyl-carrier-protein] hydrolase activity [GO:0047381]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792]"
"PGEN_.00g101990"	1.90733458136439e-06	0.0158815169671378	0.195622403792151	0.58914138250813	0.0865023920217955	"Scaffold_04"	60544962	60550985	NA	NA	NA	NA	NA
"PGEN_.00g104420"	0.0107053575466277	6.0764110795877e-05	0.885864441662548	0.610603646151227	0.154798355692345	"Scaffold_05"	1878651	1887662	NA	NA	NA	NA	NA
"PGEN_.00g104730"	0.00179852130522763	1.47216114102325e-40	0.000592312770877281	7.89564517961758e-08	8.41833900327538e-61	"Scaffold_05"	2521223	2525989	NA	NA	NA	NA	NA
"PGEN_.00g104930"	0.0421753031646171	0.0167015096756542	0.876023934803453	0.00107935861709392	0.365946942348161	"Scaffold_05"	2955313	2998718	NA	NA	NA	NA	NA
"PGEN_.00g108490"	0.00010686309429131	8.7564771216622e-07	9.37331072200299e-06	1.33248527549182e-06	0.0164634059263804	"Scaffold_05"	11321164	11322981	NA	NA	NA	NA	NA
"PGEN_.00g108510"	0.00193994181029015	8.75725669613607e-11	1.76365135483876e-05	0.0010229911204227	0.330663165345606	"Scaffold_05"	11325835	11347220	"B0KTX4"	"UBIG_PSEPG"	"Ubiquinone biosynthesis O-methyltransferase (2-polyprenyl-6-hydroxyphenol methylase) (EC 2.1.1.222) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.64)"	"GO:0006744; GO:0008425; GO:0008689; GO:0032259"	"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"
"PGEN_.00g108700"	7.80121064753775e-13	1.91943902735236e-09	0.0607308524267614	0.259460884132981	0.0925017261666406	"Scaffold_05"	11889536	11890080	NA	NA	NA	NA	NA
"PGEN_.00g110260"	0.00498003684699226	4.43673910783518e-05	3.76404193249992e-08	0.86000090138441	0.00521194087872873	"Scaffold_05"	15669855	15764255	"Q39565"	"DYHB_CHLRE"	"Dynein beta chain, flagellar outer arm"	"GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514"	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"
"PGEN_.00g116020"	2.23990460166618e-06	0.00101489186883468	0.00105066811206603	0.000145939294584597	0.455800506586844	"Scaffold_05"	32921146	32970923	"B3EWY8"	"SAAR2_ACRMI"	"Skeletal aspartic acid-rich protein 2 (Fragment)"	"GO:0016021"	"integral component of membrane [GO:0016021]"
"PGEN_.00g116710"	8.97269359572477e-28	4.22353936292422e-121	2.59268946275852e-83	1.47212029951078e-14	8.55872291008072e-32	"Scaffold_05"	34291625	34335232	"B3EWY9"	"MLP_ACRMI"	"Mucin-like protein (Fragment)"	"GO:0005509; GO:0007160; GO:0016021"	"integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]"
"PGEN_.00g119520"	0.0351165759403185	0.00241792184822169	0.302970190987948	0.845250987491855	0.0374691219898065	"Scaffold_05"	42556627	42557256	NA	NA	NA	NA	NA
"PGEN_.00g120380"	6.52007156533469e-08	3.3548057103021e-25	1.62252172053444e-06	0.0451359342816616	8.37241884463008e-06	"Scaffold_05"	45416815	45417542	NA	NA	NA	NA	NA
"PGEN_.00g122230"	0.00872412570182088	3.69600512202783e-10	0.240699728343925	0.917437020638519	0.0174371851689746	"Scaffold_05"	49655390	49656016	NA	NA	NA	NA	NA
"PGEN_.00g123920"	1.74215489421183e-11	4.36414145290199e-13	0.229018773290524	0.878677872912182	5.8266820716032e-07	"Scaffold_05"	54424415	54448483	NA	NA	NA	NA	NA
"PGEN_.00g124830"	2.04093941123998e-06	0.0016007868073842	0.000119434987462933	0.52169386436817	1.10395423066714e-05	"Scaffold_05"	56716258	56795358	"D3YXG0"	"HMCN1_MOUSE"	"Hemicentin-1 (Fibulin-6) (FIBL-6)"	"GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023"	"basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]"
"PGEN_.00g125310"	0.0103902196401872	0.000975247824036643	0.0206454835707426	0.0276946901235372	2.36311489432789e-05	"Scaffold_05"	58046068	58110568	NA	NA	NA	NA	NA
"PGEN_.00g126370"	0.00313905357096175	0.00111001969106383	0.00161527440418979	0.367156657337824	9.11016322213949e-08	"Scaffold_05"	60832377	60837710	NA	NA	NA	NA	NA
"PGEN_.00g127230"	9.72634323990389e-89	5.78553841523463e-85	1.13574222047521e-11	9.07392821166048e-08	1.4219645468309e-91	"Scaffold_05"	62825525	62833060	NA	NA	NA	NA	NA
"PGEN_.00g127570"	0.00148815595400645	2.35457211895651e-12	0.45186192210215	0.820101810707837	3.14395116475173e-17	"Scaffold_05"	63496499	63500613	NA	NA	NA	NA	NA
"PGEN_.00g129780"	2.97538495866067e-13	3.34238122362722e-34	4.83736660831317e-28	0.0476599553158026	4.89774619225082e-20	"Scaffold_06"	2364924	2385026	"P61315"	"G3ST3_MOUSE"	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	"GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694"	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]"
"PGEN_.00g130160"	3.17301847736141e-08	0.0222295668663508	0.00584581123472313	0.0113978152092618	0.0413563140748495	"Scaffold_06"	3270606	3274261	"Q8BR93"	"HARB1_MOUSE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872"	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g130700"	8.00656793954642e-40	9.98355481237555e-87	0.803124312214525	0.0812792625317584	0.725119161922698	"Scaffold_06"	4611890	4623896	NA	NA	NA	NA	NA
"PGEN_.00g131030"	1.12652095797231e-05	0.0241944468378098	0.0506008555137126	0.686472921908157	0.0307706619573291	"Scaffold_06"	5295042	5305191	"Q9NXW9"	"ALKB4_HUMAN"	"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-)"	"GO:0003779; GO:0005730; GO:0005737; GO:0006325; GO:0006482; GO:0016491; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0070938; GO:0070989; GO:0080111; GO:1902275"	"contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; demethylase activity [GO:0032451]; metal ion binding [GO:0046872]; oxidative DNA demethylase activity [GO:0035516]; oxidoreductase activity [GO:0016491]; actomyosin structure organization [GO:0031032]; chromatin organization [GO:0006325]; cleavage furrow ingression [GO:0036090]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]; regulation of chromatin organization [GO:1902275]"
"PGEN_.00g133000"	0.0251147312779643	0.0231178895099489	0.00120274161243738	0.31639334178795	9.8194129222033e-05	"Scaffold_06"	10182526	10182777	NA	NA	NA	NA	NA
"PGEN_.00g134400"	0.0107053575466277	7.04544646765944e-09	0.98325731787904	0.543182170350515	0.941443749596161	"Scaffold_06"	13548708	13578024	"P61315"	"G3ST3_MOUSE"	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	"GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694"	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]"
"PGEN_.00g134790"	0.0384680837392173	0.00967821651399364	0.50190933731229	0.0761002990993041	0.45849472530356	"Scaffold_06"	14288894	14352831	NA	NA	NA	NA	NA
"PGEN_.00g135810"	0.0324512465436505	0.0003876042462819	0.417142740814988	0.97358678855063	0.809748535974369	"Scaffold_06"	17039205	17041620	NA	NA	NA	NA	NA
"PGEN_.00g136060"	9.7582939985614e-07	0.0353978143551991	0.400590327704019	0.483620311487436	5.7609014882408e-08	"Scaffold_06"	17698759	17724650	"Q9C5D2"	"FBL4_ARATH"	"F-box/LRR-repeat protein 4 (AtFBL4)"	"GO:0006289; GO:0006511; GO:0010225; GO:0016567; GO:0019005; GO:0031146"	"SCF ubiquitin ligase complex [GO:0019005]; nucleotide-excision repair [GO:0006289]; protein ubiquitination [GO:0016567]; response to UV-C [GO:0010225]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"PGEN_.00g139530"	0.00170231775388376	0.000143902165080685	0.240699728343925	0.446467838811554	0.146692925583142	"Scaffold_06"	25730256	25730618	NA	NA	NA	NA	NA
"PGEN_.00g139540"	1.12822792537192e-13	6.17029375480073e-14	4.07777145671402e-09	0.156145790550324	3.57404847000573e-11	"Scaffold_06"	25730920	25732298	NA	NA	NA	NA	NA
"PGEN_.00g139560"	3.11967120065073e-10	1.1627905128885e-27	0.000313529746738533	0.123737982422903	1.91809658133796e-11	"Scaffold_06"	25734949	25736806	NA	NA	NA	NA	NA
"PGEN_.00g139570"	3.90054894283204e-12	1.5145588799003e-26	1.19743318569004e-07	0.000287743175805685	2.82253228439773e-15	"Scaffold_06"	25736847	25737710	NA	NA	NA	NA	NA
"PGEN_.00g140310"	1.14106539337965e-12	5.27289401880149e-42	4.17125095690759e-30	3.73305983521273e-29	2.09822654101435e-31	"Scaffold_06"	28097745	28112985	NA	NA	NA	NA	NA
"PGEN_.00g143270"	1.24728438603604e-10	3.66100929124529e-12	1.41081904054638e-23	0.0327472628487409	0.0480764529375252	"Scaffold_06"	36978300	36978638	NA	NA	NA	NA	NA
"PGEN_.00g149640"	2.77009958209978e-14	1.05956871354358e-14	1.38677054382198e-07	6.01388082433149e-56	5.32340461854331e-148	"Scaffold_06"	53208943	53234353	"Q80YX1"	"TENA_MOUSE"	"Tenascin (TN) (Hexabrachion) (Tenascin-C) (TN-C)"	"GO:0001968; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009612; GO:0010628; GO:0014012; GO:0031012; GO:0031175; GO:0042060; GO:0042475; GO:0045471; GO:0045545; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0098966"	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; perisynaptic extracellular matrix [GO:0098966]; fibronectin binding [GO:0001968]; syndecan binding [GO:0045545]; bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; odontogenesis of dentin-containing tooth [GO:0042475]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]"
"PGEN_.00g150310"	1.13040983520774e-12	0.00430536868696455	0.286191506600847	0.00914803170531275	0.427692661187393	"Scaffold_06"	55124389	55134058	NA	NA	NA	NA	NA
"PGEN_.00g151730"	6.12336440648464e-05	2.32142954786226e-08	0.221899789623106	0.00368791355786737	0.0646189861178019	"Scaffold_06"	58908250	58921822	NA	NA	NA	NA	NA
"PGEN_.00g159640"	4.20023982134783e-05	8.05135121506716e-05	0.117783908996811	0.883185081153361	0.0601774247437991	"Scaffold_07"	19130999	19146957	NA	NA	NA	NA	NA
"PGEN_.00g160750"	2.49200261353812e-19	2.74909468579827e-06	0.0790594913016486	0.0202982527374641	1.05841343767528e-08	"Scaffold_07"	22118445	22131261	NA	NA	NA	NA	NA
"PGEN_.00g164020"	1.27360345993926e-29	4.62115702849041e-11	0.00120274161243738	0.137950735410511	2.01768191001814e-05	"Scaffold_07"	30603488	30671660	"P16066"	"ANPRA_HUMAN"	"Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)"	"GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779"	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]"
"PGEN_.00g165230"	1.64287010149907e-191	1.30470836692325e-288	7.16758688557994e-17	0.149967444691797	6.35586328034082e-241	"Scaffold_07"	34059828	34064039	"Q8IWY4"	"SCUB1_HUMAN"	"Signal peptide, CUB and EGF-like domain-containing protein 1"	"GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0019897; GO:0022617; GO:0042802; GO:0045446; GO:0045880; GO:0046982; GO:0051260"	"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]"
"PGEN_.00g166530"	1.25631747095955e-10	2.28249179655276e-17	0.032172898006061	0.395430148637166	0.152296733183819	"Scaffold_07"	37881004	37904577	"Q29RK9"	"MOB3B_BOVIN"	"MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B)"	"GO:0035330; GO:0046872"	"metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330]"
"PGEN_.00g166960"	1.52225538448219e-14	7.06473342826864e-07	0.000960443634992504	0.108136253686463	0.522421196310023	"Scaffold_07"	39517604	39527641	NA	NA	NA	NA	NA
"PGEN_.00g167410"	0.00608591077152272	0.0189011349598818	0.334815703200214	0.0182436158337974	0.00264513294824947	"Scaffold_07"	40269117	40309203	"Q9Y2V3"	"RX_HUMAN"	"Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein)"	"GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0007389; GO:0007601; GO:0021854; GO:0043010; GO:0045944; GO:0060173"	"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; camera-type eye development [GO:0043010]; hypothalamus development [GO:0021854]; limb development [GO:0060173]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; visual perception [GO:0007601]"
"PGEN_.00g167890"	0	6.53383761340908e-49	2.45422345256617e-17	1.94054698114293e-84	8.41240723396327e-36	"Scaffold_07"	41687471	41690284	"Q91755"	"GRIK2_XENLA"	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Fragment)"	"GO:0005234; GO:0016021; GO:0030054; GO:0038023; GO:0045211"	"cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]"
"PGEN_.00g168070"	1.71490811788585e-44	2.28194965464875e-19	4.29756140460474e-09	6.03312872558528e-08	0.00120152606832838	"Scaffold_07"	42236821	42237171	NA	NA	NA	NA	NA
"PGEN_.00g170010"	0.00240179826072756	2.00165589730783e-08	3.02077191359046e-06	6.31917333986687e-09	1.65545240782881e-06	"Scaffold_08"	5050520	5055437	NA	NA	NA	NA	NA
"PGEN_.00g171020"	3.47026736365869e-06	0.00674855475619299	0.00121377860523756	0.314910735124238	0.700372600745351	"Scaffold_08"	7646702	7649949	"Q9H1P6"	"CT085_HUMAN"	"Uncharacterized protein C20orf85"	""	""
"PGEN_.00g171780"	0.0340367838575723	9.97113976427597e-11	0.0497186275857521	0.0237031168935883	0.0239922577794556	"Scaffold_08"	9763601	9786077	"P97363"	"SPTC2_MOUSE"	"Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)"	"GO:0004758; GO:0005739; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504"	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]"
"PGEN_.00g175550"	2.49488758999788e-18	7.95315560515245e-12	0.000531508578166095	1.83984992482806e-05	0.000125459863131163	"Scaffold_08"	20144628	20151783	"Q2TAD9"	"CYR1B_XENLA"	"Cysteine and histidine-rich protein 1-B"	"GO:0005737; GO:0008270"	"cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]"
"PGEN_.00g177130"	0.00172578149988469	0.00379365680205011	0.478601410459128	0.30934278168762	0.0144687772980479	"Scaffold_08"	24508625	24619344	NA	NA	NA	NA	NA
"PGEN_.00g178040"	8.11044403864299e-05	0.0389909141854228	0.253165349127568	0.12941671055538	0.0105975292455414	"Scaffold_08"	27273100	27296031	"Q8R4E1"	"TIP_RAT"	"T-cell immunomodulatory protein (Protein TIP) (CDA08-like protein) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)"	"GO:0005576; GO:0005886; GO:0016021"	"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]"
"PGEN_.00g179130"	0.000472424824905119	0.011738357073951	0.371659744089543	0.71574081243398	0.589732145371419	"Scaffold_08"	29733158	29751082	NA	NA	NA	NA	NA
"PGEN_.00g180330"	0.0204370331674079	0.0320715779321826	0.00120707914284034	0.0376259519178317	0.00352901763039914	"Scaffold_08"	32604271	32628380	NA	NA	NA	NA	NA
"PGEN_.00g183880"	0.00145362095416388	2.13972397797621e-11	2.87991809996169e-05	0.0495739314487863	0.00336735401712515	"Scaffold_08"	41644440	41659729	"P21894"	"SYAC_BOMMO"	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	"GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270"	"cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]"
"PGEN_.00g185010"	2.31816518987778e-06	0.00937766847488636	0.874101344027148	0.801460375859917	0.0019789115543566	"Scaffold_08"	44550419	44563488	"Q8BVI5"	"STX16_MOUSE"	"Syntaxin-16"	"GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"
"PGEN_.00g186170"	5.108502633284e-18	2.88555525854004e-10	0.000152873753681959	0.561337931469331	3.25879607187475e-22	"Scaffold_08"	47597455	47626960	"P82251"	"BAT1_HUMAN"	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	"GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003"	"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]"
"PGEN_.00g186290"	0.000118694755792296	3.84720192407329e-32	2.42634609159395e-08	0.453203400363245	1.72626831055716e-08	"Scaffold_08"	47925610	47932879	NA	NA	NA	NA	NA
"PGEN_.00g190430"	4.80199180302452e-11	0.0364649592744605	1.78042371068993e-06	5.43751877981233e-09	7.13610149754777e-10	"Scaffold_08"	59613122	59676228	"O75096"	"LRP4_HUMAN"	"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)"	"GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"	"cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g193010"	3.54857837686011e-05	2.38043072504362e-06	0.0219082800360186	4.06137242532216e-05	0.000658530655455569	"Scaffold_09"	4847684	4864676	"Q3UTY6"	"THSD4_MOUSE"	"Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4)"	"GO:0001527; GO:0008233; GO:0031012; GO:0048251"	"extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251]"
"PGEN_.00g193590"	1.68858074048012e-06	7.19004098292232e-11	0.000152873753681959	7.89564517961758e-08	0.0013449568999918	"Scaffold_09"	6762215	6762706	NA	NA	NA	NA	NA
"PGEN_.00g194760"	8.16440717457701e-08	0.00139908375222481	5.41752365011091e-06	0.0440728121759044	3.6818760863098e-05	"Scaffold_09"	10315046	10324136	NA	NA	NA	NA	NA
"PGEN_.00g196380"	0.0138495135434602	0.0113539282072798	0.667062063690312	0.00839332368724998	0.0249532242940891	"Scaffold_09"	15009763	15015551	NA	NA	NA	NA	NA
"PGEN_.00g197680"	1.54641054455131e-11	1.12857544959113e-13	2.1803133586828e-05	0.108094483690144	0.033936008120786	"Scaffold_09"	19259544	19259813	NA	NA	NA	NA	NA
"PGEN_.00g198010"	1.06405216746726e-94	3.24220515978942e-95	9.64008062951475e-218	5.46602432030074e-250	3.52517785171167e-36	"Scaffold_09"	20195697	20233222	"P05099"	"MATN1_CHICK"	"Cartilage matrix protein (Matrilin-1)"	"GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023"	"collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]"
"PGEN_.00g198290"	0.000464836522083192	5.31244261877464e-23	8.19323689470071e-58	0.0394132252514478	0.00479165863705261	"Scaffold_09"	21131080	21133028	NA	NA	NA	NA	NA
"PGEN_.00g203210"	0.00468915908276667	0.0116698050833527	0.0974661999422053	0.619037622669197	0.112410131966742	"Scaffold_09"	35860456	35860959	NA	NA	NA	NA	NA
"PGEN_.00g203340"	8.57479793176633e-05	0.0170947804693506	0.010308444614397	0.596170156848761	0.560166669370698	"Scaffold_09"	36039731	36080013	"Q32L09"	"SHFL_BOVIN"	"Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog (SHFL) (Repressor of yield of DENV protein homolog) (RyDEN)"	"GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0006449; GO:0034340; GO:0034341; GO:0034342; GO:0043022; GO:0045071; GO:0051607; GO:0075523; GO:1990825; GO:2001125"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; defense response to virus [GO:0051607]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523]"
"PGEN_.00g203450"	1.96794343219673e-05	0.00334121222672968	0.114318924718506	0.402039563199562	0.982540349571708	"Scaffold_09"	36210214	36218864	"Q9BV99"	"LRC61_HUMAN"	"Leucine-rich repeat-containing protein 61"	"GO:0005737; GO:0008104; GO:0019901"	"cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]"
"PGEN_.00g203950"	4.06955772729442e-10	0.0345094177234119	0.175787310469219	0.00158205735998533	0.00254029286055033	"Scaffold_09"	37624601	37626259	NA	NA	NA	NA	NA
"PGEN_.00g204470"	2.22765576291168e-11	4.26510178276057e-10	0.00549808825847918	0.37798687971179	0.854914676728467	"Scaffold_10"	450153	503366	"P41221"	"WNT5A_HUMAN"	"Protein Wnt-5a"	"GO:0000187; GO:0001736; GO:0001756; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002741; GO:0003323; GO:0003402; GO:0003408; GO:0003700; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007223; GO:0007257; GO:0007411; GO:0007442; GO:0007494; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030514; GO:0030665; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032729; GO:0032755; GO:0033138; GO:0034613; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0044212; GO:0045080; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045745; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048850; GO:0050680; GO:0050718; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061024; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0150012; GO:1900020; GO:1901216; GO:1902379; GO:1902474; GO:1903827; GO:1904469; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052; GO:2000484"	"cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; DNA-binding transcription factor activity [GO:0003700]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; transcription regulatory region DNA binding [GO:0044212]; activation of GTPase activity [GO:0090630]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; keratinocyte differentiation [GO:0030216]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; membrane organization [GO:0061024]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primitive streak formation [GO:0090009]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cellular protein localization [GO:1903827]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"
"PGEN_.00g207530"	6.19166593724204e-05	0.000354762236954178	0.157730274205583	0.615909473364577	1.16310532916614e-08	"Scaffold_10"	9251922	9298180	"P74148"	"Y1388_SYNY3"	"Universal stress protein Sll1388 (USP Sll1388)"	""	""
"PGEN_.00g207540"	0.00352946987819336	0.012074973073542	0.517702680995973	0.756549653815286	0.000127462083946444	"Scaffold_10"	9296424	9296879	NA	NA	NA	NA	NA
"PGEN_.00g208340"	3.67030485762219e-16	0.00497266733933713	0.826568578290717	0.385821018295093	0.000157174342498165	"Scaffold_10"	10978789	10984277	NA	NA	NA	NA	NA
"PGEN_.00g208420"	6.33634094971515e-32	4.39124576399093e-09	8.34067118032795e-05	0.45733018036077	0.420852660372938	"Scaffold_10"	11112293	11113880	NA	NA	NA	NA	NA
"PGEN_.00g208580"	1.51022692051445e-76	2.07059469491715e-23	1.03136977839068e-38	0.314910735124238	3.8494403659649e-72	"Scaffold_10"	11353032	11413765	"Q3L254"	"WNT7B_CHICK"	"Protein Wnt-7b"	"GO:0005109; GO:0005615; GO:0016055; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048018; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089"	"extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055]"
"PGEN_.00g211830"	0.00298653749416712	8.33429332391007e-06	4.01904499928186e-09	0.15880710215687	9.42502300001256e-33	"Scaffold_10"	21025397	21043857	"P16056"	"MET_MOUSE"	"Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)"	"GO:0000122; GO:0000187; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010800; GO:0010801; GO:0010828; GO:0010976; GO:0014069; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0033138; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043005; GO:0043025; GO:0043235; GO:0043274; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0051897; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:1900407; GO:1900745; GO:1901299; GO:1905098; GO:2001028"	"basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"
"PGEN_.00g213350"	3.99758363185048e-63	1.52179251136889e-17	0.359930006418995	1.76493897431915e-20	1.16242473609187e-09	"Scaffold_10"	24367809	24391529	"Q5U3U3"	"CPT2_DANRE"	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	"GO:0004095; GO:0005739; GO:0005743; GO:0006635"	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]"
"PGEN_.00g213360"	0.013402559375916	0.0274593199406645	0.00414119254851334	0.149967444691797	0.864764194147284	"Scaffold_10"	24403902	24509214	"Q14995"	"NR1D2_HUMAN"	"Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)"	"GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0090575; GO:0097009; GO:2001014"	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; multicellular organism development [GO:0007275]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; response to lipid [GO:0033993]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
"PGEN_.00g213500"	8.05738782303742e-21	0.0132248327595873	0.644352426820407	0.935896482208528	0.404248597731215	"Scaffold_10"	24757026	24779906	"P9WQE8"	"PHAS_MYCTO"	"Phthioceranic/hydroxyphthioceranic acid synthase (EC 2.3.1.-) (Polyketide synthase pks2)"	"GO:0006633; GO:0016491; GO:0016746; GO:0031177"	"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; fatty acid biosynthetic process [GO:0006633]"
"PGEN_.00g216290"	0.0116211393913051	2.66241519009438e-09	0.349808815767504	0.0332100715752805	0.00010477079400529	"Scaffold_10"	32485490	32510624	"Q5XPI4"	"RN123_HUMAN"	"E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)"	"GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]"
"PGEN_.00g218470"	0.0254000317172343	0.0214094479527275	0.691549002550553	0.613433815192121	0.591189627284116	"Scaffold_10"	37942795	37962271	"O14594"	"NCAN_HUMAN"	"Neurocan core protein (Chondroitin sulfate proteoglycan 3)"	"GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0043202"	"extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]"
"PGEN_.00g220560"	0.0188704756927024	3.26616983777862e-05	2.56559300898401e-13	0.0438851569428797	0.511276364382711	"Scaffold_10"	43341952	43342467	NA	NA	NA	NA	NA
"PGEN_.00g223280"	0.019293980008198	0.0156773561610978	0.7730122697658	0.0275330999195033	0.00123928089999415	"Scaffold_10"	49846134	49868144	"Q7Z9I2"	"YCP9_SCHPO"	"Uncharacterized oxidoreductase C663.09c (EC 1.-.-.-)"	"GO:0005634; GO:0005829; GO:0016491; GO:0110095"	"cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]"
"PGEN_.00g227520"	0.0386060368858011	0.0382379150397033	0.01038450755642	0.844456997729494	0.199706684371924	"Scaffold_11"	9517456	9568849	"Q17LW0"	"MYO7A_AEDAE"	"Myosin-VIIa (Protein crinkled)"	"GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015"	"cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]"
"PGEN_.00g228070"	4.19447590360049e-06	1.42085663191848e-07	0.529461758155989	0.954687641489269	7.78396200029728e-08	"Scaffold_11"	10700226	10712002	NA	NA	NA	NA	NA
"PGEN_.00g228480"	2.09597286987359e-08	1.3724909299495e-06	0.19458040467369	0.223425414260027	0.272623702348025	"Scaffold_11"	11464828	11497042	"A6H611"	"MIPEP_MOUSE"	"Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59)"	"GO:0004175; GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872"	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]"
"PGEN_.00g229290"	2.99102527255322e-10	0.000108809164121385	0.793247929762094	5.68871319245863e-08	3.76728046866151e-06	"Scaffold_11"	14384730	14401505	"P33274"	"CP4F1_RAT"	"Cytochrome P450 4F1 (EC 1.14.14.1) (CYPIVF1) (Cytochrome P450-A3)"	"GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0009636; GO:0019369; GO:0020037; GO:0043231; GO:0050544; GO:0070330"	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]; response to toxic substance [GO:0009636]"
"PGEN_.00g231770"	3.88337077143344e-65	2.38491594613431e-27	5.26145303244884e-46	1.03829268871114e-23	6.87310962916746e-19	"Scaffold_11"	22208396	22220228	NA	NA	NA	NA	NA
"PGEN_.00g232510"	0.000945502560712184	0.0380446624501858	0.849698990611881	0.00254694457203479	0.00052782666575276	"Scaffold_11"	24540511	24560772	NA	NA	NA	NA	NA
"PGEN_.00g233360"	1.50659266182294e-34	1.32304852598568e-26	3.13137481516856e-15	5.01625188404943e-60	5.15525605229357e-07	"Scaffold_11"	26583481	26583714	NA	NA	NA	NA	NA
"PGEN_.00g233560"	3.41644729154677e-07	3.29411102905541e-07	0.500375447657143	0.314910735124238	0.179583719063422	"Scaffold_11"	26992313	27006977	"Q8CHI9"	"CHSTF_RAT"	"Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)"	"GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659"	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]"
"PGEN_.00g234920"	2.6103944552448e-05	0.000753448044953572	6.47449880113536e-06	0.160760371715348	7.78396200029728e-08	"Scaffold_11"	30429298	30430197	NA	NA	NA	NA	NA
"PGEN_.00g237880"	0.0142437684501582	0.0477752922441708	0.952399744279913	0.722974837374853	0.77430008964347	"Scaffold_11"	39686157	39788739	NA	NA	NA	NA	NA
"PGEN_.00g241500"	0.000120578624420251	0.0447339326116856	0.297547648909045	4.81466101927918e-05	0.186238977065101	"Scaffold_11"	49013433	49014510	NA	NA	NA	NA	NA
"PGEN_.00g243120"	0.0359600810040183	1.07933098275466e-10	0.000138507239598722	0.176584761407447	0.580190693625506	"Scaffold_12"	2015031	2025800	NA	NA	NA	NA	NA
"PGEN_.00g245920"	0.00272832904894314	0.000112044076940847	0.00191592071943769	0.0724069180772028	0.0407364231531465	"Scaffold_12"	9268299	9326841	"Q99973"	"TEP1_HUMAN"	"Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)"	"GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
"PGEN_.00g252700"	1.15487296794581e-14	0.000145333668578858	1.84444702566956e-06	0.190198447299144	1.11918630034627e-08	"Scaffold_12"	30351169	30367057	"Q9ESQ5"	"TRPM4_RAT"	"Transient receptor potential cation channel subfamily M member 4 (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (MLS2s) (Melastatin-like 2)"	"GO:0002250; GO:0002407; GO:0002724; GO:0005227; GO:0005262; GO:0005509; GO:0005516; GO:0005524; GO:0005623; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006816; GO:0007204; GO:0008284; GO:0010460; GO:0016925; GO:0019722; GO:0030502; GO:0034706; GO:0035774; GO:0042310; GO:0043025; GO:0044214; GO:0045600; GO:0045668; GO:0045907; GO:0051289; GO:0071318; GO:0086045; GO:0086047; GO:0086048; GO:0086091; GO:0089717; GO:0090263; GO:0098662; GO:0098719; GO:0098911; GO:1903949; GO:1904179; GO:1904199"	"cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; adaptive immune response [GO:0002250]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310]"
"PGEN_.00g252770"	0.0369259856606066	0.0291798697743716	1.04372725733055e-12	0.717411387090808	0.253454974438225	"Scaffold_12"	30498877	30511673	NA	NA	NA	NA	NA
"PGEN_.00g252880"	0.0097034109922073	0.0222295668663508	0.313006498223701	0.0206616214309506	0.134467999836885	"Scaffold_12"	31035393	31048475	NA	NA	NA	NA	NA
"PGEN_.00g259110"	3.54857837686011e-05	0.000941306659954018	0.355293346797325	0.709424941993455	0.190196327923264	"Scaffold_12"	49282970	49346357	"Q99666"	"RGPD5_HUMAN"	"RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63)"	"GO:0005634; GO:0005643; GO:0005737; GO:0006607; GO:0008536; GO:0043547"	"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]"
"PGEN_.00g263790"	2.4734270637564e-08	0.000255186933408191	0.482081601196047	0.581243406817477	3.82882964019241e-09	"Scaffold_13"	11481800	11500700	"Q9I926"	"FUCL6_ANGJA"	"Fucolectin-6"	"GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088"	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
"PGEN_.00g266080"	0.00436291323535289	0.0238498241435688	0.826568578290717	0.364217971200052	0.420852660372938	"Scaffold_13"	17657227	17658915	NA	NA	NA	NA	NA
"PGEN_.00g270020"	0.000984166166334832	0.023661270992646	0.920689470719069	0.084543488290265	4.12413600170001e-05	"Scaffold_13"	28530263	28600990	"Q6P1L5"	"F117B_HUMAN"	"Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein)"	""	""
"PGEN_.00g270640"	0.0167404001180037	0.0220809249535981	0.937525850314864	0.026267591804721	0.75836841702707	"Scaffold_13"	30124160	30148040	"Q2KID4"	"DNAL1_BOVIN"	"Dynein light chain 1, axonemal"	"GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504"	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]"
"PGEN_.00g270670"	0.0297707224100823	0.0203622038568379	0.12351472779954	0.65966599947537	0.00149879080293908	"Scaffold_13"	30231477	30232532	NA	NA	NA	NA	NA
"PGEN_.00g271680"	0.00159803007432835	3.26599593919398e-13	4.42262010123756e-14	0.000485084221402946	4.08880574255561e-12	"Scaffold_13"	33018431	33030805	"Q5U504"	"KLH40_XENLA"	"Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5)"	"GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032436; GO:0048741; GO:0098528"	"A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]"
"PGEN_.00g273120"	4.72708613963314e-19	4.1632128690085e-08	0.0455507246879678	0.145911539572318	0.722467624329226	"Scaffold_13"	36730996	36746071	"O26153"	"IPK_METTH"	"Isopentenyl phosphate kinase (IPK) (EC 2.7.4.26)"	"GO:0005524; GO:0008299; GO:0016301; GO:0102043"	"ATP binding [GO:0005524]; isopentenyl phosphate kinase activity [GO:0102043]; kinase activity [GO:0016301]; isoprenoid biosynthetic process [GO:0008299]"
"PGEN_.00g276560"	0.0153192775545163	0.00212955635269289	0.0136396275784925	0.00175969020125766	0.635314562875776	"Scaffold_14"	1546749	1553206	NA	NA	NA	NA	NA
"PGEN_.00g277360"	2.07794667254711e-19	2.18262925350665e-05	3.57466834432105e-17	0.58090120071781	0.110513272068221	"Scaffold_14"	3377810	3378106	NA	NA	NA	NA	NA
"PGEN_.00g277910"	4.4767466219471e-124	3.5581042648159e-85	4.5254471541642e-46	2.95627480949376e-11	1.47145743606294e-28	"Scaffold_14"	4509691	4540589	"Q61165"	"SL9A1_MOUSE"	"Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)"	"GO:0002026; GO:0005516; GO:0005623; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014070; GO:0014704; GO:0015385; GO:0015386; GO:0016020; GO:0016323; GO:0016324; GO:0030307; GO:0030315; GO:0030346; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0042383; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051930; GO:0055007; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902533; GO:1902600; GO:1903281"	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular sodium ion homeostasis [GO:0006883]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; response to organic cyclic compound [GO:0014070]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]"
"PGEN_.00g278820"	4.20859715071636e-44	1.18310598215687e-15	1.67069610468078e-88	0.000694257070684539	1.01172382756703e-05	"Scaffold_14"	6530037	6533107	NA	NA	NA	NA	NA
"PGEN_.00g279140"	1.9063954100382e-81	4.33663941559202e-32	1.18777079513547e-16	3.37345096737783e-104	1.25437906418519e-90	"Scaffold_14"	6934908	6946622	"P50164"	"TRN2_HYONI"	"Tropinone reductase 2 (EC 1.1.1.236) (Tropinone reductase II) (TR-II)"	"GO:0009710; GO:0050358"	"tropinone reductase activity [GO:0050358]; tropane alkaloid biosynthetic process [GO:0009710]"
"PGEN_.00g279710"	2.81543913435524e-07	3.05954934117183e-11	3.13137481516856e-15	0.792573678814274	0.475334962826341	"Scaffold_14"	8544876	8566105	NA	NA	NA	NA	NA
"PGEN_.00g279730"	5.45877178265447e-13	0.000145281204914492	2.63800087567427e-15	0.748335708993681	1.38531835254799e-19	"Scaffold_14"	8594867	8627802	"Q5R6S0"	"ABHGA_PONAB"	"Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23)"	"GO:0004620; GO:0006660; GO:0016021; GO:0047372; GO:0052651; GO:1905344"	"integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]"
"PGEN_.00g279870"	2.82104199140841e-05	5.75359695593736e-17	0.0864670721817365	0.715168256271042	0.0172002265056404	"Scaffold_14"	9058523	9112116	"P00522"	"ABL_DROME"	"Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)"	"GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005912; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499"	"adherens junction [GO:0005912]; apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"
"PGEN_.00g282450"	5.7934699538019e-17	2.80090584924018e-05	0.920689470719069	0.99366946958415	0.880973775034998	"Scaffold_14"	15054143	15088020	NA	NA	NA	NA	NA
"PGEN_.00g283380"	0.000261789446262793	0.000608858996323151	0.447411354781361	0.740749440320274	7.9268429812837e-20	"Scaffold_14"	17328982	17400089	"Q9XTQ6"	"TBH1_CAEEL"	"Tyramine beta-hydroxylase (EC 1.14.17.-)"	"GO:0004500; GO:0004836; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421; GO:0045202"	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; tyramine-beta hydroxylase activity [GO:0004836]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
"PGEN_.00g284710"	1.17071721629921e-05	2.57752026371384e-05	1.23602227170897e-05	0.0060123210060919	3.74458183601611e-64	"Scaffold_14"	20971964	20979053	NA	NA	NA	NA	NA
"PGEN_.00g285330"	3.35377711984553e-22	5.26214336555898e-10	1.23649098782073e-17	0.000166253705858709	3.30910587839876e-05	"Scaffold_14"	22480283	22493744	NA	NA	NA	NA	NA
"PGEN_.00g286080"	8.97849598616596e-07	2.55650036636155e-12	0.00236466294934965	0.00969919975457538	0.845478223185777	"Scaffold_14"	24120924	24142993	NA	NA	NA	NA	NA
"PGEN_.00g289060"	0.0121473585427963	0.0295688807010268	0.569843802944779	0.385821018295093	0.289943235246011	"Scaffold_14"	29616418	29622077	NA	NA	NA	NA	NA
"PGEN_.00g289090"	6.9999695203134e-05	2.79663988445674e-05	0.014230114852335	0.0140838487837403	0.986861722791369	"Scaffold_14"	29650979	29662232	"E9Q5G3"	"KIF23_MOUSE"	"Kinesin-like protein KIF23"	"GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149"	"cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]"
"PGEN_.00g291910"	7.59354194203148e-83	2.01041719168378e-21	1.27059436128725e-182	0.786151097303722	1.38480073598601e-31	"Scaffold_14"	35949839	35966065	"Q4PJX1"	"ODR4_MOUSE"	"Protein odr-4 homolog (mODR-4)"	"GO:0008104; GO:0016021"	"integral component of membrane [GO:0016021]; protein localization [GO:0008104]"
"PGEN_.00g291920"	1.50972701314974e-25	1.27295131179581e-26	0.00135098043131589	4.47244894640964e-05	0.00510709680995733	"Scaffold_14"	35980565	35989129	NA	NA	NA	NA	NA
"PGEN_.00g292360"	2.44287549553439e-09	0.00337059402985498	1.62830704837643e-05	0.577757749927598	0.00274293815446852	"Scaffold_14"	36958778	36970352	NA	NA	NA	NA	NA
"PGEN_.00g295080"	2.05397350429577e-32	8.78138529728774e-18	0.952399744279913	0.42473836933408	0.201087726636572	"Scaffold_14"	43231713	43232399	NA	NA	NA	NA	NA
"PGEN_.00g295480"	1.76254021053524e-35	3.77032418861279e-45	5.60559464634012e-41	0.411452458303515	1.64409321254238e-33	"Scaffold_14"	43606617	43620277	NA	NA	NA	NA	NA
"PGEN_.00g299840"	4.12993846141888e-13	0.00163729523331008	0.00246643523910897	0.86000090138441	8.53785882851644e-06	"Scaffold_15"	7038040	7046342	NA	NA	NA	NA	NA
"PGEN_.00g302860"	4.07493744222091e-08	2.72381341115097e-14	0.101061264865538	3.68653763384382e-38	2.88001769935698e-35	"Scaffold_15"	14475444	14494663	"Q6NT16"	"S18B1_HUMAN"	"MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)"	"GO:0016021; GO:0055085"	"integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]"
"PGEN_.00g304250"	0.017509385562031	0.000410943263392854	0.00993253798745698	0.314910735124238	1.03548926889551e-06	"Scaffold_15"	18341336	18341860	NA	NA	NA	NA	NA
"PGEN_.00g304260"	0.0436234761167819	0.000483503692765805	0.00430751763269992	0.314824811377977	0.113028264113489	"Scaffold_15"	18342004	18342573	NA	NA	NA	NA	NA
"PGEN_.00g304920"	0.00576439157107399	6.72436113666199e-06	0.0699827786030994	0.992818421063455	0.0698598036004491	"Scaffold_15"	19709067	19710275	NA	NA	NA	NA	NA
"PGEN_.00g304970"	8.51475328347281e-08	0.00195596599261518	0.987077418171846	0.633513514701837	0.449063979869807	"Scaffold_15"	19841457	19849321	"D2GZW6"	"VRTN_AILME"	"Vertnin"	"GO:0004803; GO:0006313; GO:0043565"	"sequence-specific DNA binding [GO:0043565]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]"
"PGEN_.00g305680"	2.01785992177055e-06	0.000352867222794435	0.0153161923027104	0.191794819458757	3.49365845767882e-09	"Scaffold_15"	21853239	21888214	"O88873"	"GMEB2_RAT"	"Glucocorticoid modulatory element-binding protein 2 (GMEB-2)"	"GO:0000978; GO:0000981; GO:0001228; GO:0003713; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
"PGEN_.00g308500"	0.0396262290800826	0.00127429728856342	0.88587335453489	0.843459250955331	0.201087726636572	"Scaffold_15"	28670414	28674256	"Q15386"	"UBE3C_HUMAN"	"Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2)"	"GO:0000209; GO:0000502; GO:0004842; GO:0005634; GO:0006511; GO:0061631"	"nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"PGEN_.00g308970"	9.25141044725216e-26	8.06522706251792e-09	0.00590963707571896	1.60921177529929e-11	8.13902919127236e-06	"Scaffold_15"	30256878	30261165	"Q93075"	"TATD2_HUMAN"	"Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)"	"GO:0005634; GO:0005654; GO:0016888; GO:0036498; GO:0046872"	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]"
"PGEN_.00g309570"	1.297080624731e-10	0.00699232361507253	0.944950385990651	0.801460375859917	0.519973349793069	"Scaffold_15"	31898261	31953724	NA	NA	NA	NA	NA
"PGEN_.00g310520"	4.68198972543139e-05	4.87027927931461e-05	0.339313535673039	0.449101917041325	0.0237580334150565	"Scaffold_15"	34581787	34614741	NA	NA	NA	NA	NA
"PGEN_.00g311190"	7.14671120691433e-06	0.0259087752324865	3.9876290544e-09	0.59044533246329	0.000512838904794042	"Scaffold_15"	36259441	36264805	"B8NM66"	"USTA_ASPFN"	"Ribosomally synthesized cyclic peptide ustiloxin B precursosr (Ustiloxin B biosynthesis protein A) [Cleaved into: YAIG-I; YAIG-II; YAIG-III; YAIG-IV; YAIG-V; YAIG-VI; YAIG-VII; YAIG-VIII; YAIG-IX; YAIG-X; YAIG-XI; YAIG-XII; YAIG-XIII; YAIG-XIV; YAIG-XV; YAIG-XVI]"	""	""
"PGEN_.00g311750"	1.7270861119996e-05	0.000387841796590917	4.57000090505302e-09	0.00027198764726015	3.74688416315205e-12	"Scaffold_15"	37693159	37710893	NA	NA	NA	NA	NA
"PGEN_.00g312440"	0.00755164391186482	0.00430533361321242	0.00134195206544972	0.366893942856766	0.671779134427608	"Scaffold_15"	39426630	39540564	"Q4V8B0"	"OXR1_RAT"	"Oxidation resistance protein 1 (Protein C7)"	"GO:0005730; GO:0005739; GO:0006979; GO:0007628; GO:0016491; GO:0043524; GO:0051402; GO:0071447; GO:1900408; GO:1902083; GO:1903204"	"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; oxidoreductase activity [GO:0016491]; adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979]"
"PGEN_.00g312690"	1.95261166442312e-27	9.32882632808692e-08	0.000604925825389172	0.000785721959660744	2.21950279544421e-05	"Scaffold_15"	40337744	40343589	"Q6AZB8"	"HARB1_DANRE"	"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"	"GO:0004518; GO:0005634; GO:0005737; GO:0046872"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"PGEN_.00g316050"	0.00110391061610272	4.31670656415039e-05	0.000977101690941986	0.801460375859917	2.02905881955566e-05	"Scaffold_16"	459215	459469	NA	NA	NA	NA	NA
"PGEN_.00g316170"	4.15627215498851e-09	7.80242471740883e-12	1.34656420915597e-07	0.045073755564789	0.79758901471678	"Scaffold_16"	790566	822937	"Q5ZIJ9"	"MIB2_CHICK"	"E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)"	"GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567"	"cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]"
"PGEN_.00g322650"	1.29691595075483e-44	6.21786844472049e-39	0.00365354169520244	0.145911539572318	5.63900666906101e-51	"Scaffold_16"	18248077	18261946	"P22699"	"GUN6_DICDI"	"Endoglucanase (EC 3.2.1.4) (Cellulase) (Endo-1,4-beta-glucanase) (Spore germination protein 270-6)"	"GO:0005576; GO:0008810; GO:0009847; GO:0030245; GO:0030248; GO:0030435"	"extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]; spore germination [GO:0009847]; sporulation resulting in formation of a cellular spore [GO:0030435]"
"PGEN_.00g326070"	2.83979233286576e-07	1.186028606726e-06	0.0169176050285366	0.4728308379175	0.425500993372291	"Scaffold_16"	28622353	28656089	"Q5U249"	"ELYS_XENLA"	"Protein ELYS (Protein MEL-28) (xELYS)"	"GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028"	"cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA transport [GO:0051028]; protein transport [GO:0015031]"
"PGEN_.00g328960"	5.51916196176263e-24	9.83406935462925e-14	1.98231221812466e-06	1.2745391470121e-05	3.62843563289569e-26	"Scaffold_17"	4818154	4836910	"B3EWZ8"	"ECT_ACRMI"	"Ectin (Fragment)"	"GO:0005576"	"extracellular region [GO:0005576]"
"PGEN_.00g333540"	0.00493960696454359	0.0109151391974097	0.0330100298227017	0.722974837374853	0.194424887793499	"Scaffold_17"	19207496	19252244	"Q86TI4"	"WDR86_HUMAN"	"WD repeat-containing protein 86"	""	""
"PGEN_.00g333690"	2.22765576291168e-11	1.75310853031608e-09	4.38182916225311e-10	1.63792683341268e-05	3.01064396424771e-07	"Scaffold_17"	19655402	19663314	NA	NA	NA	NA	NA
"PGEN_.00g334400"	3.90984339002125e-88	3.5490586962976e-10	0.000150261103128458	0.324459626699347	0.178602019675029	"Scaffold_17"	21776739	21871098	"O01761"	"UNC89_CAEEL"	"Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89)"	"GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905"	"A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]"
"PGEN_.00g336030"	9.25717992022673e-08	0.00425581337082155	0.790436079062402	0.643337311963661	0.00188406342550593	"Scaffold_17"	26753895	26778865	"O88327"	"CTNL1_MOUSE"	"Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1)"	"GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015"	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]"
"PGEN_.00g336040"	0.0252589343063598	0.0156186765160203	0.233187681074085	0.717104279031869	0.45849472530356	"Scaffold_17"	26809399	26813144	NA	NA	NA	NA	NA
"PGEN_.00g337030"	0.00356555911361461	0.0343538330411136	0.546223946138263	0.689866031085536	0.904678644360368	"Scaffold_17"	29320344	29399120	"Q9W0S9"	"DIP2_DROME"	"Disco-interacting protein 2"	"GO:0003824; GO:0005634; GO:0007275"	"nucleus [GO:0005634]; catalytic activity [GO:0003824]; multicellular organism development [GO:0007275]"
"PGEN_.00g337830"	0.00249504162574228	1.59499104521907e-05	0.659884654964079	0.793899330510244	0.00071824050713944	"Scaffold_17"	31545329	31552546	NA	NA	NA	NA	NA
"PGEN_.00g337850"	2.87464045048805e-26	2.01660825365111e-09	0.149642756996541	0.717104279031869	9.09693611676453e-14	"Scaffold_17"	31636351	31656066	"Q8Q0U0"	"Y045_METMA"	"Putative ankyrin repeat protein MM_0045"	""	""
"PGEN_.00g342450"	2.38829347613209e-39	4.59615658912402e-13	1.40367055153237e-20	0.636084371320491	2.91219874256901e-20	"Scaffold_18"	9065419	9065829	NA	NA	NA	NA	NA
"PGEN_.00g345410"	1.98297932550517e-21	1.7184893167571e-162	1.02307055572594e-68	4.14603088324134e-07	5.68276820468256e-53	"Scaffold_18"	16460541	16500267	"Q29485"	"PLMN_ERIEU"	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	"GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771"	"extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]"
